Shanghai ZJ Bio-Tech Co., Ltd.
SHH: 688317.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Junbin Shao
- Employees
- 305
- Headquarters
- Shanghai, China
- IPO year
- 2021
- Market cap
- CN¥4.0B
- Website
- https://www.liferiver.com.cn
Loading 688317…
Loading profile data…Frequently asked questions about 688317
What does Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) do?
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular genetic diagnostic reagents, and instruments and equipment in China. The company was founded in 2005 and is based in Shanghai, China.
Where does 688317.SS trade?
Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) trades on the Shanghai Stock Exchange.
What sector is 688317.SS in?
Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai ZJ Bio-Tech Co., Ltd.?
Junbin Shao is the chief executive officer of Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS).
Where is Shanghai ZJ Bio-Tech Co., Ltd. headquartered?
Shanghai ZJ Bio-Tech Co., Ltd. is headquartered in China.
Does 688317.SS pay a dividend?
Yes — Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) paid a trailing twelve-month dividend of CNY 0.11 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688317.SS go public?
Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) completed its initial public offering in 2021.